10-Q: Franklin BSP Capital Reports Mixed Q2, Portfolio Shifts

Franklin BSP Capital Corporation reported a decrease in net investment income for Q2 2025 but an increase for the six months ended June 30, 2025, driven by portfolio growth from the FBLC merger, alongside significant net realized and unrealized losses.

Summary

• Total investment income decreased to $103.4 million for the three months ended June 30, 2025, from $104.6 million in the prior year, primarily due to lower SOFR rates.
• Total investment income increased to $210.9 million for the six months ended June 30, 2025, from $201.2 million in the prior year, largely due to the acquisition of $2.8 billion in FBLC investments in January 2024.
• Net investment income decreased to $39.6 million for the three months ended June 30, 2025, from $48.7 million in the prior year, and decreased to $84.5 million for the six months ended June 30, 2025, from $98.4 million in the prior year.
• Total expenses increased to $62.7 million for the three months ended June 30, 2025, from $55.1 million in the prior year, and to $125.0 million for the six months ended June 30, 2025, from $101.5 million in the prior year, mainly due to higher interest and debt fees.
• Net realized loss was $(11.5) million for the three months ended June 30, 2025, and $(8.0) million for the six months ended June 30, 2025, primarily due to a $14.0 million loss from the restructuring of Coronis Health LLC's first lien debt position.
• Net change in unrealized depreciation on investments was $(1.9) million for the three months ended June 30, 2025, and $(25.4) million for the six months ended June 30, 2025, driven by deteriorating credit performance in certain portfolio companies.
• The company's investment portfolio stood at $4.08 billion at fair value as of June 30, 2025, with 85.7% in debt investments and 14.3% in equity/other investments.
• The weighted average risk rating of investments remained at 2.2 as of June 30, 2025, and December 31, 2024.
• Nine portfolio companies were on non-accrual status as of June 30, 2025, representing $125.4 million amortized cost and $74.7 million fair value (3.0% and 1.8% of the portfolio, respectively).
• The company's asset coverage ratio was 178% as of June 30, 2025, exceeding the 150% regulatory requirement.
• The company had $535.1 million in available borrowing capacity under its credit facilities as of June 30, 2025.

Sentiment

Score: 4

Explanation: The sentiment is moderately negative due to the significant net realized and unrealized losses, particularly from credit deterioration in certain portfolio companies, and the decline in net investment income for the quarter. While the company maintains a strong asset coverage ratio and has expanded its credit facilities, the underlying portfolio performance and increased expenses present challenges.

Positives

• The company's total investment income for the six months ended June 30, 2025, increased to $210.9 million, primarily due to the strategic acquisition of FBLC's investment portfolio.
• The company maintains a strong asset coverage ratio of 178%, well above the 150% regulatory minimum, indicating a healthy financial leverage position.
• The weighted average risk rating of the investment portfolio remained stable at 2.2, suggesting consistent credit quality despite market fluctuations.
• The company successfully amended its JPM Credit Facility, increasing commitments to $1.05 billion and reducing the applicable margin to 2.15%, improving borrowing terms.
• The JPM Revolver Facility was also amended and restated, increasing aggregate commitments to $780.0 million and extending its maturity, enhancing liquidity and flexibility.

Negatives

• Net investment income decreased for the three months ended June 30, 2025, to $39.6 million from $48.7 million in the prior year, partly due to lower SOFR rates.
• The company recorded a net realized loss of $(11.5) million for the three months and $(8.0) million for the six months ended June 30, 2025, including a significant $(14.0) million loss from the restructuring of Coronis Health LLC's debt.
• Net change in unrealized appreciation (depreciation) on investments resulted in a depreciation of $(25.4) million for the six months ended June 30, 2025, primarily due to deteriorating credit performance in certain portfolio companies.
• Operating expenses, particularly interest and debt fees, significantly increased due to higher average daily debt outstanding, impacting overall profitability.
• Nine portfolio companies are on non-accrual status as of June 30, 2025, indicating concerns about principal or interest collection from these investments.

Risks

• Market risk from interest rate fluctuations, as net investment income is dependent on the difference between borrowing and investment rates, and increasing rates could reduce income.
• Valuation risk due to the illiquid nature of debt and equity securities of private companies, where fair value determination involves subjective judgments and estimates, potentially differing from actual liquidation values.
• Inflation and supply chain risks could affect the profit margins of portfolio companies, impacting their ability to make payments.
• Credit risk associated with portfolio companies, as evidenced by the deterioration in credit performance of some investments leading to unrealized losses and non-accrual status.
• Dependence on the Adviser and its affiliates for essential services, including asset management and administrative responsibilities, posing a risk if these entities are unable to provide services.

Future Outlook

The company expects to have sufficient liquidity for its investing activities and to conduct operations for the next 12 months. It continues to explore forms of debt financing, including new or expanded credit facilities or the issuance of senior securities, to meet short and long-term liquidity requirements and potentially increase returns through leverage.

Management Comments

• Management's conclusions regarding tax positions taken may be subject to review and adjustment at a later date based on factors including, but not limited to, examination by tax authorities on-going analysis of and changes to tax laws, regulations and interpretations thereof.
• Management feels that the likelihood of future events resulting in the execution of indemnification provisions against the company is remote, based on its history and experience.

Industry Context

The company operates within the U.S. middle market lending sector, primarily focusing on senior secured loans. Its performance is influenced by broader economic conditions, interest rate environments (such as SOFR rates), and the level of merger and acquisition activity in the middle market. The continued elevated inflation and global supply chain issues are noted as potential pressures on portfolio company profit margins.

Comparison to Industry Standards

• The company's portfolio composition, with 85.7% in debt investments (91.9% if underlying SLF and certain other investments are reclassified as senior secured first lien), aligns with typical BDC strategies focused on income generation through debt instruments.
• The asset coverage ratio of 178% is healthy and exceeds the regulatory minimum, indicating prudent leverage management compared to industry benchmarks.
• The weighted average risk rating of 2.2 suggests a generally stable credit quality within its middle market loan portfolio, which is a key indicator for direct lending funds.

Management Changes

Legal Proceedings

• The company is not currently party to any material pending legal proceedings, and no such material proceedings are known to be contemplated.

Related Party Transactions

• The company pays Franklin BSP Capital Adviser L.L.C. (the Adviser) a base management fee and an incentive fee for investment advisory and management services.
• The company reimburses Benefit Street Partners (the Administrator) for administrative costs and expenses incurred under the Administration Agreement.
• The Adviser waived all Incentive Fees for the period from January 7, 2021, to December 31, 2023.
• The company co-invests in portfolio companies with other funds managed by the Adviser or its affiliates (Affiliated Entities) under an SEC exemptive order, subject to certain conditions.

Stakeholder Impact

• Shareholders: Impacted by decreased net asset value per share, lower net investment income, and significant realized/unrealized losses, but also benefit from continued distributions and potential for future capital appreciation.
• Creditors: Debt obligations are secured by the company's assets, and the company maintains a healthy asset coverage ratio, indicating a strong ability to meet its debt obligations.
• Portfolio Companies: Subject to ongoing monitoring and risk grading by the company's Adviser, with some experiencing deteriorating credit performance leading to non-accrual status.
• Employees (indirectly, through Adviser/Administrator): The company reimburses the Administrator for allocable costs of its Chief Compliance Officer, Chief Financial Officer, and their respective staffs.

Next Steps

• The company is obligated to file a registration statement with the SEC for an exchange offer of the 2029 Notes for new registered notes, or a shelf registration statement for resale, to satisfy registration obligations.
• The company will continue to make quarterly distributions to stockholders, with the next regular quarterly distribution of $0.29 per share of Common Stock and $19.12 per share of Series A Preferred Stock declared for payment around September 2, 2025.

Key Dates

Recommendation

The company exhibits mixed financial performance, with a decline in net investment income for the quarter and significant realized and unrealized losses from its investment portfolio, indicating some credit deterioration. While the strategic merger has expanded its asset base and it maintains a strong asset coverage ratio, the current challenges in portfolio performance and increased expenses warrant a cautious approach. The recent amendments to credit facilities are positive for liquidity, but the overall outlook is tempered by the non-accrual status of several investments. A 'hold' recommendation is appropriate as investors should monitor the stabilization of portfolio credit quality and the impact of interest rate changes on net investment income before making further commitments.

Keywords

BDC, Business Development Company, Middle Market Lending, Senior Secured Loans, Private Credit, Investment Portfolio, SEC Filing, Financial Results, Debt Financing, Unrealized Losses, Non-Accrual Loans, Interest Rate Risk